Frea Sloot1, Hans L J Hoeve2, Marlou L A de Kroon3, André Goedegebure2, Jill Carlton4, Helen J Griffiths5, Huibert J Simonsz6. 1. Department of Ophthalmology, Erasmus University Medical Center Rotterdam, the Netherlands f.sloot@erasmusmc.nl. 2. Department of Otorhinolaryngology, Erasmus University Medical Center Rotterdam, the Netherlands. 3. Department of Public Health, Erasmus University Medical Center Rotterdam, the Netherlands. 4. Health Economics and Decision Science (HEDS), School of Health and Related Research (ScHARR), University of Sheffield, UK. 5. Academic Unit of Ophthalmology & Orthoptics, University of Sheffield, UK. 6. Department of Ophthalmology, Erasmus University Medical Center Rotterdam, the Netherlands.
Abstract
OBJECTIVE: To examine the diversity in paediatric vision and hearing screening programmes in Europe. METHODS: Themes for comparison of screening programmes derived from literature were used to compile three questionnaires on vision, hearing, and public health screening. Tests used, professions involved, age, and frequency of testing seem to influence sensitivity, specificity, and costs most. Questionnaires were sent to ophthalmologists, orthoptists, otolaryngologists, and audiologists involved in paediatric screening in all EU full-member, candidate, and associate states. Answers were cross-checked. RESULTS: Thirty-nine countries participated; 35 have a vision screening programme, 33 a nation-wide neonatal hearing screening programme. Visual acuity (VA) is measured in 35 countries, in 71% of these more than once. First measurement of VA varies from three to seven years of age, but is usually before age five. At age three and four, picture charts, including Lea Hyvarinen, are used most; in children over four, Tumbling-E and Snellen. As first hearing screening test, otoacoustic emission is used most in healthy neonates, and auditory brainstem response in premature newborns. The majority of hearing testing programmes are staged; children are referred after 1-4 abnormal tests. Vision screening is performed mostly by paediatricians, ophthalmologists, or nurses. Funding is mostly by health insurance or state. Coverage was reported as >95% in half of countries, but reporting was often not first-hand. CONCLUSION: Largest differences were found in VA charts used (12), professions involved in vision screening (10), number of hearing screening tests before referral (1-4), and funding sources (8).
OBJECTIVE: To examine the diversity in paediatric vision and hearing screening programmes in Europe. METHODS: Themes for comparison of screening programmes derived from literature were used to compile three questionnaires on vision, hearing, and public health screening. Tests used, professions involved, age, and frequency of testing seem to influence sensitivity, specificity, and costs most. Questionnaires were sent to ophthalmologists, orthoptists, otolaryngologists, and audiologists involved in paediatric screening in all EU full-member, candidate, and associate states. Answers were cross-checked. RESULTS: Thirty-nine countries participated; 35 have a vision screening programme, 33 a nation-wide neonatal hearing screening programme. Visual acuity (VA) is measured in 35 countries, in 71% of these more than once. First measurement of VA varies from three to seven years of age, but is usually before age five. At age three and four, picture charts, including Lea Hyvarinen, are used most; in children over four, Tumbling-E and Snellen. As first hearing screening test, otoacoustic emission is used most in healthy neonates, and auditory brainstem response in premature newborns. The majority of hearing testing programmes are staged; children are referred after 1-4 abnormal tests. Vision screening is performed mostly by paediatricians, ophthalmologists, or nurses. Funding is mostly by health insurance or state. Coverage was reported as >95% in half of countries, but reporting was often not first-hand. CONCLUSION: Largest differences were found in VA charts used (12), professions involved in vision screening (10), number of hearing screening tests before referral (1-4), and funding sources (8).
Authors: Anita Gáborján; Gábor Katona; Miklós Szabó; Béla Muzsik; Marianna Küstel; Mihály Horváth; László Tamás Journal: Eur Arch Otorhinolaryngol Date: 2022-06-29 Impact factor: 3.236
Authors: Anna Budai; András Czigler; Eszter Mikó-Baráth; Vanda A Nemes; Gábor Horváth; Ágota Pusztai; David P Piñero; Gábor Jandó Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-10-03 Impact factor: 3.117
Authors: Rajan Sharma; Yuanyuan Gu; Teresa Y C Ching; Vivienne Marnane; Bonny Parkinson Journal: Appl Health Econ Health Policy Date: 2019-06 Impact factor: 2.561